Evidence map›Paper›PMID 27832774›Full record

Observational studyRespiratory research2016

Spirometric variability in smokers: transitions in COPD diagnosis in a five-year longitudinal study.

Akshay Sood, Hans Petersen, Clifford Qualls, Paula M Meek, Rodrigo Vazquez-Guillamet, Bartolome R Celli, Yohannes Tesfaigzi

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Respiratory research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 48 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Review
  13. Acute Exacerbation and Longitudinal Lung Function Change of Preserved Ratio Impaired Spirometry.International journal of chronic obstructive pulmonary disease · 2024
    Article
  14. Article
  15. Associations Between Muscle Weakness and Clinical Outcomes in Current and Former Smokers.Chronic obstructive pulmonary diseases (Miami, Fla.) · 2023
    Article
  16. The Clinical Spectrum of PRISm.American journal of respiratory and critical care medicine · 2022
    Article
  17. Article
  18. Article
  19. Asthma-COPD overlap in World Trade Center Health Registry enrollees, 2015-2016.The Journal of asthma : official journal of the Association for the Care of Asthma · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Akshay SoodDepartment of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM, USA. asood@salud.unm.edu.
Hans PetersenCOPD program, Lovelace Respiratory Research Institute, Albuquerque, NM, USA.
Clifford QuallsOffice of Research, University of New Mexico Health Sciences Ctr, Albuquerque, NM, USA.
Paula M MeekUniversity of Colorado College of Nursing, Denver, CO, USA.
Rodrigo Vazquez-GuillametDepartment of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM, USA.
Bartolome R CelliDepartment of Internal Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Yohannes TesfaigziCOPD program, Lovelace Respiratory Research Institute, Albuquerque, NM, USA.
University of New Mexico · USLovelace Respiratory Research Institute · USColorado College · USHarvard University · US

Funding

Resolution of Epithelial Cell Hyperplasia in AsthmaR01HL068111 · NHLBI · LOVELACE BIOMEDICAL & ENVIRONMENTAL RESEARCH INSTITUTE · PI TESFAIGZI, YOHANNES · 2003 to 2021
$10.9M
University of New Mexico Clinical and Translational Science CenterUL1TR000041 · NCATS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI LARSON, RICHARD S · 2012 to 2014
$9.8M
Resolution of Epithelial Cell HyperplasiaR01ES015482 · NIEHS · LOVELACE BIOMEDICAL & ENVIRONMENTAL RESEARCH INSTITUTE · PI TESFAIGZI, YOHANNES · 2009 to 2013
$2.6M
Novel role for adiponectin-enhancing drugs for asthma in the obeseR01HS023093 · AHRQ · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI SOOD, AKSHAY · 2014 to 2014
$395k
AHRQ HHS R01 HS023093NCATS NIH HHS UL1 TR000041NHLBI NIH HHS R01 HL068111NIEHS NIH HHS R01 ES015482
6 · The paper itself

Abstract

backgroundSpirometrically-defined chronic obstructive pulmonary disease (COPD) is considered progressive but its natural history is inadequately studied. We hypothesized that spirometrically-defined COPD states could undergo beneficial transitions.

methodsParticipants in the Lovelace Smokers' Cohort (n = 1553), primarily women, were longitudinally studied over 5 years. Spirometric states included normal postbronchodilator spirometry, COPD Stage I, Unclassified state, and COPD Stage II+, as defined by GOLD guidelines. Beneficial transitions included either a decrease in disease severity, including resolution of spirometric abnormality, or maintenance of non-diseased state. 'All smokers' (n = 1553) and subgroups with normal and abnormal spirometry at baseline (n = 956 and 597 respectively) were separately analyzed. Markov-like model of transition probabilities over an average follow-up period of 5 years were calculated.

resultsAmong 'all smokers', COPD Stage I, Unclassified, and COPD Stage II+ states were associated with probabilities of 16, 39, and 22 % respectively for beneficial transitions, and of 16, 35, and 4 % respectively for resolution. Beneficial transitions were more common for new-onset disease than for pre-existing disease (p < 0.001). Beneficial transitions were less common among older smokers, men, or those with bronchial hyperresponsiveness but more common among Hispanics and smokers with excess weight.

conclusionsThis observational study of ever smokers, shows that spirometrically-defined COPD states, may not be uniformly progressive and can improve or resolve over time. The implication of these findings is that the spirometric diagnosis of COPD can be unstable. Furthermore, COPD may have a pre-disease state when interventions might help reverse or change its natural history.

trial registrationNA.

Indexed as

SmokersSpirometryAgedChi-Square DistributionComorbidityDisease ProgressionFemaleForced Expiratory VolumeHispanic or LatinoHumansLinear ModelsLongitudinal StudiesLungMaleMarkov ChainsMiddle Aged

Identifiers

PMID27832774
PMCPMC5105293
OpenAlexW2554080418

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.